Policy | August 04, 2021
India Initiates anti dumping probe against import of ATS-8 from China
Arch Pharma Labs has filed the application
Arch Pharma Labs has filed the application
It is designed to tackle mental health issues
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Turnover of API division of ISLL stood at Rs 856.58 crore
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Subscribe To Our Newsletter & Stay Updated
